News and Views
Recent Price Movement and Market Context
Pfizer Ltd.’s stock price has underperformed its sector and the broader market in the short term. Over the past week, the stock has declined by 1.58%, contrasting with a 0.23% gain in the Sensex benchmark. Year-to-date, the stock is marginally down by 0.55%, though it has outpaced the Sensex’s 2.82% decline during the same period. Over the longer term, Pfizer has delivered a robust 20.56% return in the last year, significantly outperforming the Sensex’s 9.35% gain. However, its three- and five-year returns lag behind the benchmark, with 29.31% and 9.75% respectively, compared to the Sensex’s 36.45% and 62.73%.
On the technical front, Pfizer’s current price sits above its 20-day and 50-day moving averages but remains below the 5-...
Read full news article
